Register      Login
Australian Journal of Primary Health Australian Journal of Primary Health Society
The issues influencing community health services and primary health care
Shopping Cart: ( empty )
You are here: Home > Journals > PY > PY24143 > Fulltext
RESEARCH ARTICLE
Contents Vol 30(6)

Uptake of guideline-based testing for chronic viral hepatitis in Australian primary care: retrospective analysis of electronic medical record data

Jennifer H. MacLachlan A B * , Nicole Allard A B C , Lien Tran A B , Amelia Savage A , Emily Adamson D , Vanessa Price E , Christopher Pearce F , Gregory J. Dore E and Benjamin C. Cowie https://orcid.org/0000-0002-7087-5895 A B G
+ Author Affiliations
- Author Affiliations

A WHO Collaborating Centre for Viral Hepatitis, The Peter Doherty Institute for Infection and Immunity, The Doherty Institute, Melbourne, Vic, Australia.

B University of Melbourne, Parkville, Vic, Australia.

C Cohealth, Footscray, Vic, Australia.

D The Burnet Institute, Melbourne, Vic, Australia.

E The Kirby Institute, UNSW, Sydney, NSW, Australia.

F Outcome Health, Blackburn, Vic, Australia.

G Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Vic, Australia.

* Correspondence to: Jennifer.maclachlan@mh.org.au

Australian Journal of Primary Health 30, PY24143 https://doi.org/10.1071/PY24143
Submitted: 8 September 2024  Accepted: 28 November 2024  Published: 12 December 2024

© 2024 The Author(s) (or their employer(s)). Published by CSIRO Publishing on behalf of La Trobe University

Abstract

Background

Diagnosis is essential for engagement in care for chronic hepatitis B (CHB) and chronic hepatitis C (CHC), however, many Australians remain undiagnosed, especially for CHB. Primary care represents an important setting for testing, and this study sought to examine coverage in a large representative cohort of patients.

Methods

We analysed retrospective data from the electronic medical records of active patients visiting 566 primary care clinics in Victoria, Australia. Pathology records were assessed to identify the proportion of patients with a record of CHB/CHC serology testing based on risk factors identified in national guidelines (ethnicity, Indigenous status, history of injecting drug use, diagnosed HIV, and/or indications of liver disease).

Results

Of 1,593,774 patients, 393,948 (24.7%) had an indication for testing for CHB and/or CHC, of which 150,821 (38.3%) had evidence of testing. This proportion was highest in patients with HIV (65.6%) or injecting drug use history (60.0%), and lowest for those whose Indigenous status/ethnicity indicated testing (38.2%) or with elevated liver enzymes (39.1%). The proportion with evidence of testing was only moderate among those with a cirrhosis diagnosis (48.6%) or probable cirrhosis based on laboratory testing (50.6%).

Conclusions

This analysis demonstrated considerable gaps in testing for CHB and CHC in a large population of patients, including many with evidence of cirrhosis, suggesting higher risk of adverse outcomes. Primary care practices should be supported to comprehensively offer testing for viral hepatitis, particularly where there is evidence of liver disease, and these findings should be used to guide future interventions.

Keywords: epidemiology, general practice, hepatitis B, hepatitis C, liver cancer, primary care, public health, screening, testing.

References

Allard NL, MacLachlan JH, Tran L, Yussf N, Cowie BC (2021) Time for universal hepatitis B screening for Australian adults. Medical Journal of Australia 215, 103-105.e1.
| Crossref | Google Scholar | PubMed |

ASHM (2020a) National Hepatitis B Testing Policy. Available at http://testingportal.ashm.org.au/national-hbv-testing-policy/

ASHM (2020b) National Hepatitis C Testing Policy. Available at http://testingportal.ashm.org.au/national-hcv-testing-policy/

Australian Government Department of Health (2018a) Fifth National Hepatitis C Strategy 2018–2022. Australian Government Department of Health, Canberra. Available at https://www.health.gov.au/resources/publications/fifth-national-hepatitis-c-strategy-2018-2022?language=en [Accessed 11 February 2019]

Australian Government Department of Health (2018b) Third National Hepatitis B Strategy 2018–2022. Australian Government Department of Health, Canberra. Available at https://www.health.gov.au/sites/default/files/documents/2022/06/third-national-hepatitis-b-strategy-2018-2022.pdf

Australian Government Department of Health and Aged Care (2023) Screening for cancer. Available at https://www.health.gov.au/topics/cancer/screening-for-cancer

Australian Government Department of Health and Ageing (2007) National Hepatitis C Testing Policy. Hepatitis C Subcommittee of the Ministerial Advisory Committee on AIDS, Sexual Health and Hepatitis; the Blood Borne Virus and Sexually Transmissible Infections Subcommittee of the Australian Population Health Development Committee.

Chak E, Li C-S, Chen MS, Jr, MacDonald S, Bowlus C (2020) Electronic health record alerts enhance mass screening for chronic hepatitis B. Scientific Reports 10, 19153.
| Crossref | Google Scholar |

Gooey M, Wong E, Pedrana A, Allard N, Doyle J, Hellard M, Wade A (2020) A survey of Australian general practitioners’ hepatitis C knowledge and management 2 years after subsidised direct-acting antiviral therapy became available. Sexual Health 17, 387-389.
| Crossref | Google Scholar | PubMed |

Iversen J, Dore GJ, Starr M, Catlett B, Cunningham P, Geddes L, Maher L (2020) Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia: pre and post availability of direct acting antiviral therapy. International Journal of Drug Policy 83, 102837.
| Crossref | Google Scholar | PubMed |

Kwon JA, Dore GJ, Hajarizadeh B, Alavi M, Valerio H, Grebely J, Guy R, Gray RT (2021) Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complications. PLoS ONE 16, e0257369.
| Crossref | Google Scholar | PubMed |

MacLachlan J, Stewart S, Cowie B (2021) Viral Hepatitis Mapping Project: Geographic diversity in chronic hepatitis B and C prevalence, management and treatment. National Report 2020. ASHM, Darlinghurst, NSW, Australia. Available at https://ashm.org.au/wp-content/uploads/2022/04/ASHM_ViralHepReport_2020_WEB_final.pdf

MacLachlan J, Romero N, Purcell I, Cowie B (2024a) Viral Hepatitis Mapping Project: Hepatitis B. National Report 2022. ASHM, Darlinghurst, NSW, Australia. Available at https://ashm.org.au/vh-mapping-project/

MacLachlan J, Romero N, Purcell I, Cowie B (2024b) Viral Hepatitis Mapping Project: Hepatitis C. National Report 2021–2023. ASHM, Darlinghurst, NSW, Australia. Available at https://ashm.org.au/vh-mapping-project/

McCulloch K, Romero N, MacLachlan J, Allard N, Cowie B (2020) Modeling progress toward elimination of hepatitis B in Australia. Hepatology 71, 1170-1181.
| Crossref | Google Scholar | PubMed |

McCulloch K, Romero N, MacLachlan JH, Cowie BC (2021) National Surveillance for Hepatitis B Indicators: Measuring the progress towards the targets of the National Hepatitis B Strategy – Annual Report 2020. WHO Collaborating Centre for Viral Hepatitis, The Doherty Institute, Melbourne. Available at https://www.doherty.edu.au/whoccvh/centre-activities/blood-borne-viruses-and-sexually-transmissible-infections-surveillance-and-research-programme

Mnatzaganian G, MacLachlan JH, Allard N, Brown C, Rowe S, Cowie BC (2023) Missed opportunities for diagnosis of hepatitis B and C in individuals diagnosed with decompensated cirrhosis or hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 38, 976-983.
| Crossref | Google Scholar | PubMed |

Pearce C, McLeod A, Rinehart N, Ferrigi J, Shearer M (2019) What a comprehensive, integrated data strategy looks like: the population level analysis and reporting (POLAR) program. Studies in Health Technology and Informatics 264, 303-307.
| Crossref | Google Scholar | PubMed |

Quinn E, Massey P, Rosewell A, Smith M, Durrheim D (2014) Improving ethnocultural data to inform public health responses to communicable diseases in Australia. Western Pacific Surveillance and Response Journal 5, 1-4.
| Crossref | Google Scholar | PubMed |

Richmond JA, Sasadeusz J, Temple-Smith M (2018) The role of primary health care in hepatitis B testing and management: a case study. Journal of Community Health 43, 38-47.
| Crossref | Google Scholar | PubMed |

Samji H, Yu A, Kuo M, Alavi M, Woods R, Alvarez M, Dore GJ, Tyndall M, Krajden M, Janjua NZ, Team BCHTC (2017) Late hepatitis B and C diagnosis in relation to disease decompensation and hepatocellular carcinoma development. Journal of Hepatology 67, 909-917.
| Crossref | Google Scholar | PubMed |

Sidlow R, Msaouel P (2015) Improving hepatitis C virus screening rates in primary care: a targeted intervention using the electronic health record. Journal for Healthcare Quality 37, 319-323.
| Crossref | Google Scholar | PubMed |

Smith BC, Watson KJ (1995) Management of the chronic hepatitis B carrier. Australian Family Physician 24, 331-339.
| Google Scholar | PubMed |

Swerissen H, Duckett S (2018) Mapping primary care in Australia. The Grattan Institute, Melbourne. Available at https://grattan.edu.au/wp-content/uploads/2018/07/906-Mapping-primary-care.pdf

The CDA Foundation (2023) Locations achieving relative or absolute impact and programmatic targets – HCV by country/Territory – trending 2023 data. Available at https://cdafound.org/polaris/elimination-maps/ [Accessed 15 November 2024]

The Kirby Institute (2020) National update on HIV, viral hepatitis and sexually transmissible infections in Australia: 2009–2018. The Kirby Institute, The University of New South Wales, Sydney. Available at http://kirby.unsw.edu.au/surveillance/Annual-Surveillance-Reports

The Royal Australian College of General Practitioners (2015) Clinical indicators for Australian general practice. The Royal Australian College of General Practitioners, Melbourne. Available at https://www.racgp.org.au/FSDEDEV/media/documents/Running%20a%20practice/Practice%20resources/Clinical-indicators-for-Australian-general-practice-(2).doc

van Gemert C, Wang J, Simmons J, Cowie B, Boyle D, Stoove M, Enright C, Hellard M (2016) Improving the identification of priority populations to increase hepatitis B testing rates, 2012. BMC Public Health 16, 95.
| Crossref | Google Scholar | PubMed |

van Gemert C, Howell J, Wang J, Stoove M, Cowie B, Allard N, Enright C, Dunn E, Towell V, Hellard M (2017) Knowledge and practices of chronic hepatitis B virus testing by general practitioners in Victoria, Australia, 2014-15. Australian Family Physician 46, 683-689.
| Google Scholar | PubMed |

Wallace J, McNally S, Richmond J, Hajarizadeh B, Pitts M (2012) Challenges to the effective delivery of health care to people with chronic hepatitis B in Australia. Sexual Health 9, 131-137.
| Crossref | Google Scholar | PubMed |

Wolffram I, Petroff D, Batz O, Jedrysiak K, Kramer J, Tenckhoff H, Berg T, Wiegand J, German Check-Up 35+ Study Group (2015) Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios. Journal of Hepatology 62, 1256-1264.
| Crossref | Google Scholar | PubMed |

World Health Organization (2017) Guidelines on hepatitis B and C testing. World Health Organization, Geneva. Available at https://www.who.int/hepatitis/publications/guidelines-hepatitis-c-b-testing/en/